The Boston startup said its deal with the New York - based
Spinal Muscular Atrophy Foundation calls for two years of research and development funding from the foundation.
Healthy mice will rear about six times, mice
with spinal muscular atrophy treated with both therapies reared about four times and mice with either drug alone only reared about two times.
«This is the first study done that identifies a target, JNK3, that's independent of the genetic mutation
of spinal muscular atrophy for novel therapeutic development.»
«We don't know yet if the SMN lnc - RNA actually plays a role in the disease, but it is a convenient target that we've used to our advantage to
treat spinal muscular atrophy in mice,» says Sumner.
This year, for example, scientists in Germany and at the health institutes showed that valproic acid, an epilepsy drug, could more than double S.M.N. protein levels in cell cultures taken from
spinal muscular atrophy patients.
We cloned the gene for neuromuscular degeneration in a mouse model for a lethal infantile form of SMA known
as spinal muscular atrophy with respiratory distress.
Cameron, now 3 years old, almost died as a baby
from spinal muscular atrophy but a new drug appears to have preserved the motor neurons that control his muscles.
The closest approximation to another RNAi success comes from Ionis Pharmaceuticals and Biogen, which last year received approval for Spinraza, a drug aimed
at spinal muscular atrophy.
New York, NY — September 24, 2004 — Researchers at Columbia University, Children's Hospital Boston and The Children's Hospital of Philadelphia have established a clinical research network to
study spinal muscular atrophy (SMA), the leading genetic killer of infants and toddlers.
April 24 - Drugmaker Biogen Inc's quarterly revenue missed analysts» estimates on Tuesday as it had disappointing sales of its promising drug Spinraza to treat
spinal muscular atrophy because fewer new patients used the expensive treatment.
Congratulations to Umrao Monani, Assistant Professor at the Motor Neuron Center of Columbia University and Cathleen Lutz, Associate Director of Genetic Research Science at The Jackson Laboratory, and their colleagues for their new publication «Postsymptomatic Restoration of SMN Rescues the Disease Phenotype in a Mouse Model of
Severe Spinal Muscular Atrophy» in the Journal of -LSB-...]
PROVIDENCE, R.I. [Brown University]-- Scientists and doctors know that the devastating
disease spinal muscular atrophy (SMA) arises from a problem with both copies of the SMN1 gene, leading to a lack of the survival motor neuron (SMN) protein.
Nusinersen and similar compounds being developed for
spinal muscular atrophy focus on increasing or making more of the SMN gene product that gets converted into usable protein.
Though spinal muscular atrophy (SMA) in its most severe form remains incurable and fatal in early childhood, researchers are sustaining a multipronged counterattack for patients and their families.
In a recent study published in the December 15th issue of Human Molecular Genetics, Dr. Gangwani and his team of researchers at TTUHSC El Paso describe how mice with
spinal muscular atrophy saw great improvement when the JNK3 enzyme was genetically inhibited to eliminate its activity.
Ataxia Congenital muscular dystrophy Congenital myasthenic syndrome Fronto - temporal lobe dementia Hereditary motor neuropathies — Charcot - Marie - Tooth disease Hereditary spastic paraplegias Huntington's disease Muscular channelopathy Muscular
dystrophy Spinal muscular atrophy — Lower motor neuron disease
The SMA Foundation has worked in partnership with several
other Spinal Muscular Atrophy organizations to establish national and international networks of clinics ready for clinical trials.
From a clinical perspective, Jessell's findings have paved the way for the treatment of neurodegenerative diseases,
notably spinal muscular atrophy and Lou Gehrig's disease.
He was a post-doctoral fellow at the Children's Hospital of Eastern Ontario in Ottawa, working on identification of genes associated with
human spinal muscular atrophy.
Genetic circuitry of Survival motor neuron, the gene
underlying spinal muscular atrophy Proc Natl Acad Sci U S A. 2013 Jun 11; Authors: Sen A, Dimlich DN, Guruharsha KG, Kankel MW, Hori K, Yokokura T, Brachat S, Richardson D, Loureiro J, Sivasankaran R, Curtis D, Davidow LS, Rubin LL, Hart AC, Van Vactor D, Artavanis - Tsakonas S
2013 May 16; Authors: Kissel JT, Elsheikh B, King WM, Freimer M, Scott CB, Kolb S, Reyna SP, Crawford TO, Simard LR, Krosschell KJ, Acsadi G, Schroth MK, D'Anjou G, Lasalle B, Prior TW, Sorenson S, Maczulski JA, Swoboda KJ, For the Project Cure
Spinal Muscular Atrophy Investigators» Network
The National Institute of Neurological Disease and Stroke recently
designated spinal muscular atrophy as the model for its new approach to funding «translational research.»
About
SMA Spinal Muscular Atrophy (SMA) is a rare, and often fatal, genetic disorder that affects approximately 1 in every 10,000 births.
Hereditary spinal muscular atrophy: an autosomal dominant degenerative disease of motor neurons characterized by weakness and muscle atrophy with a typical gait, and progressing to dangling of the head and a drooping, paralyzed tail.
a. Spinal muscular atrophy; b. Multiple sclerosis; c. Spinal stenosis; d. Locked - in syndrome; e. Severe conversion disorder; f. Traumatic spinal injury; g. Parkinson's disease; and h. Huntingdon's disease
If you would prefer to make a donation via check (with no minimum), please send to the following address:
Spinal Muscular Atrophy Foundation, 888 Seventh Ave., Suite 400, New York, NY 10019.
Phrases with «spinal muscular atrophy»